First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients
Conditions: Esophageal Cancer; Pancreas Cancer; Ovarian Cancer; Liver Cancer Intervention: Biological: IL15-transpresenting WT1-targeted Dendritic Cell Vaccine Sponsors: University Hospital, Antwerp; Kom Op Tegen Kanker; Stichting tegen Kanker Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Hospitals | Research | Vaccines | Wilm's Tumor